These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36604930)

  • 1. [Problems and strategy of further development of Chinese medicinal materials with edible values].
    Lyu CG; Kang CZ; Yang J; Wang S; Wang RS; Wan XF; Guo LP
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6810-6816. PubMed ID: 36604930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research status and strategy of quality control of medicinal and edible food].
    Liu CQ; Ren Y; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3963-3967. PubMed ID: 35850856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application and safety evaluation of plant growth regulators in traditional Chinese medicine].
    Zhang LX; Mou Y; Yang MH; Yu J; Tang DY; Guo F; Gu Z; Luo ZL; Ma XJ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1824-1832. PubMed ID: 32489066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present situation and development strategy of Alpinia oxyphylla].
    Yan XX; Ren BL; Wang MY; Wang QL; Yang Q; Tang H; Wang ZN
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1960-1964. PubMed ID: 31342727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research practice and strategy of resource utilization of residues for edible medicinal plants under background of Big Health].
    Zeng HT; Dai D; He XQ; Tian YY; Wang XQ; Yu JB; Li J; Liao WB
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3968-3976. PubMed ID: 35850857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Land use strategy of ecological agriculture of Chinese materia medica in future development].
    Wang HY; Kang CZ; Zhang WJ; Zhou LY; Wan XF; Lyu CG; Huang LQ; Liu DH; Guo LP
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(9):1990-1995. PubMed ID: 32495543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Main characteristics and practical discussions of national drug standards for 196 kinds of Chinese medicine formula granules].
    Lu L; Shi JH; Zhang D; Ma LJ; Zhang L; Hou FG; Miao Y; Gui XJ; Li XL; Liu RX
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4536-4544. PubMed ID: 36046883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research status and prospects of integration of habitat processing and processing of Chinese medicinal decoction pieces].
    Zhang W; Zhang JB; He TY; Qin YW; Yang JJ; Li L; Ji D; Wu QN; Wang DH; Lu TL
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2565-2571. PubMed ID: 35718474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application strategy of artificial intelligence technology in feed-based development of medicinal and edible homologous traditional Chinese medicine(TCM)resources in era of the "antibiotic ban"].
    Shao QQ; Xiao P; Zhang X; Guo S; Duan JA
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):344-353. PubMed ID: 38403310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bletilla striata ecological planting patterns and technical principle analysis].
    Jin-Qiang Z; Tao Z; Cheng-Hong X; Wei-Ke J; Lan-Ping G; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):5042-5047. PubMed ID: 33350281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chinese medicinal materials industry during the 14th Five-Year Plan period: trends and development suggestions].
    Wan XF; Wang S; Kang CZ; Lyu CG; Guo LP; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1144-1152. PubMed ID: 35343138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-value utilization technology and approach of Chinese medicinal residues under background of "Dual Carbon"].
    Fang YY; Chen N; Xiao P; Zhang S; Liu HF; Su SL; Guo S; Duan JA
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5142-5151. PubMed ID: 38114104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brief discussion about role and measures of scientific fertilization in ecological cultivation of Chinese medicinal materials].
    Ya-Qin Z; Qiu-Lin D; Qiu-Shu W; Jie-Yu X; Zhen-Huai YU; Si-Jia LI; Zhi-Wei L; Xing-Fu C
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4846-4852. PubMed ID: 33350255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current situation and problems of national standards for Chinese medicinal materials].
    Wu JY; Li C; Wu CY; Hu HB; Jin HY; Wei F; Xu ZL; Zhou YH
    Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(22):6004-6010. PubMed ID: 34951193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of model for multidimensional evaluation of value and risk of Chinese patent medicine].
    Li G; Li ZK; Yang HJ; Zhan ZL; Li HM; Tang SH
    Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1284-1292. PubMed ID: 33787124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Market quality surveillance and analysis of chinese medicinal materials and decoction pieces in 2017].
    Zhang P; Li MH; Shi Y; Cheng XL; Yan H; Liu W; Wei F; Ma SC
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4198-4202. PubMed ID: 30583617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Review of contributing factors and research model of "excellent shape, high quality, and superior effect" of Dao-di herbs].
    Yuan Y; Zheng H; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(15):3977-3985. PubMed ID: 39307732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Accurate positioning and analysis on health function of high frequency anti-fatigue herbal medicines].
    Ma LL; Lin JZ; Liu HY; Liu HM; Huang W; Tan P; Han L; Xu RC; Zhang DK
    Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3608-3616. PubMed ID: 32893550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cultivation strategy on cluster brand of ecological agriculture of Dao-di herbs].
    Kang CZ; Wang S; Huang LQ; He YL; Zhang WJ; Ma WQ; Wan XF; Wang RS; Zhou T; Guo LP
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(9):1996-2001. PubMed ID: 32495544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
    Ai YL; Tang JY; Zhou G; Zhang L; Qu LP; Huang SY; Yang ZQ; Yuan WA; Zhou YH; Wang T; Zhao JN; Sun XB; Xiao XH; Yang ZF; Liu QQ; Zhu MJ; Leng XY; Xie CG; Chai SY
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):1120-1125. PubMed ID: 35285213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.